Cutaneous response to intradermal histamine in lung cancer.
Recent evidence has suggested that human neoplastic patients show decreased blood histamine levels and cutaneous responses to intradermal histamine. In this study we evaluate the skin response to intradermal injections of histamine and IgE levels in 34 male patients with lung cancer (of which 21 had metastasis) and in 16 control subjects. Analysis of our data does not reveal any difference in the areas of wheal and flare between control subjects and lung cancer patients with or without metastasis. Moreover the evaluation of the different histologic cell type of lung cancer provides the same results. In addition, the sensitivity (Histamine Threshold Concentration) and reactivity (slopes) to histamine is not statistically different. No difference is found for IgE levels between controls and cancer patients. In the light of our finding we believe that in lung cancer patients skin response to intradermal histamine is not decreased, and therefore that the hypothesis concerning the existence of H1-histamine receptor antagonist released by tumour is not confirmed.
Cavigioli
G
G
Servizio di Broncopneumologia e Fisiopatologia Respiratoria G. Campari, Ospedale Città di Sesto S. Giovanni, Italy.
Mastropasqua
B
B
Pelucchi
A
A
Mazza
P
P
Marazzini
L
L
D000368:Aged; D006632:Histamine / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D008175:Lung Neoplasms / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012882:Skin Tests
D007073:Immunoglobulin E; D006632:Histamine